FDALabel for drug repurposing studies and beyond

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · International Journal of Antimicrobial Agents · 2020 · 5K citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +10

Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Mayla Gabriela Silva Borba, Fernando Val, Vanderson de Souza Sampaio et al. · JAMA Network Open · 2020 · 977 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Study of pharmacogenomic information in FDA-approved drug labeling to facilitate application of precision medicine

Darshan Mehta, Ryley Uber, Taylor Ingle et al. · Drug Discovery Today · 2020 · 58 citations · Full text

Medicine, Pharmacology, Pharmacogenetics +16

FDA drug labeling: rich resources to facilitate precision medicine, drug safety, and regulatory science

Hong Fang, Stephen Harris, Zhichao Liu et al. · Drug Discovery Today · 2016 · 56 citations · Full text

Medicine, Pharmacology, Drug Information +16

Clinical Evidence Supporting Pharmacogenomic Biomarker Testing Provided in US Food and Drug Administration Drug Labels

Bo Wang, William J. Canestaro, Niteesh K. Choudhry · JAMA Internal Medicine · 2014 · 46 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17